Delivery Order SPE2DB22D1103-SPE2DB24FTMQ5

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,364.06 firm fixed-price contract is for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication, through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,841.64 firm fixed-price delivery order is for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,714.35, is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a medication used for the treatment of respiratory conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. This award is not associated with a...
This federal contract award, valued at $1,213.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a medication used to treat respiratory conditions. This is a firm fixed-price delivery order contract with an ultimate completion date of April 23, 2025. The contract is not set aside for any specific business type....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. The contract has a ceiling value of $30,898.43 and runs through January 14, 2025. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,283.76 firm fixed-price delivery order is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication. The contract has a performance period ending on August 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for delivering a wide range of...
This contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products. The contract has a ceiling value of $21,794.84 and runs through February 6, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,571.66, is for the delivery of fluticasone-salmeterol 115-21 12GM, a medication used for the treatment of respiratory conditions. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price delivery order. This award is part of a larger...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,046.19 firm fixed-price delivery order is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.06 delivery order is for the supply of Fluticasone-Salmeterol 45-21 12GM, a medication used in the treatment of respiratory conditions. The contract has an ultimate completion date of October 17, 2024 and is a Firm Fixed Price agreement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTMQ5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a Firm Fixed Price Delivery Order for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,866.88 and an ultimate completion date of June 25, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:16 AM